Cuban and the US advance in biotechnology exchanges

HAVANA, Cuba, Mar 20 (acn) Cuba and the US are on the way to negotiate the use of Cuban biotechnological products for the caring and treatment of American patients, announced in Havana Doctor Agustin Lage, director of Center of Molecular Immunology.

According to the renowned scientist this is one of the two most important steps within the framework of a dialogue between the scientist community of Cuba and the United States.

Cuba has certified over 30 drugs at the US Patent and Trademark Office, he said, and ¨we are urging to open channels to facilitate access (to the American people) to our drugs and then move from an academic collaboration to a business one¨

¨We are referring to business opportunities for companies of both countries that could benefit our people in aspects as the control and prevention of non-transmissible diseases, Lage said Up today, several American organizations and centers have shown their interest in Cuban biotechnological and pharmaceutical products, a line that have become one of the most profitable and exportable Cuban products Likewise, due to the new scenario, it is foreseen that Cuban researchers can, in the short term, start clinical trials in American institutions, he said.

We have handed US entities information on Cuban patented drugs; if this process goes smoothly, they would be sold in the US, Lage added
However, he stressed, these relations will not reach their full potential as long as the economic, financial and commercial US blockade on Cuba remains in force.